Stephanie Robinson

I am a Clinical Trials Coordinator in the Oxford Primary Care Clinical Trials Unit where I support the set-up, recruitment, day-to-day running, and completion of clinical trials.  I am currently working on SuMMiT-D, which is investigating the use of a digital system that uses text messages to support people with type 2 diabetes. I joined the CTU in May 2014 and have worked on a variety of trials within the cardiovascular and infectious diseases themes including:

• PRINCIPLE - A UK-wide clinical platform trial from the University of Oxford to find COVID-19 treatments for recovery at home
• PACE – Point of care testing to target antibiotics for chronic obstructive pulmonary disease exacerbations
• EDGE – A pilot study and randomised trial of a multi-component mobile-health based intervention compared with usual care to improve outcomes in chronic obstructive pulmonary disease
• StAR2D – SMS supporting treatment for people with type 2 diabetes in sub-Saharan Africa: a pragmatic individually randomised trial
• POC HbA1c – Introducing HbA1c point-of-care testing into primary care
• ATAFUTI - Alternative Treatments of Adult Female Urinary Tract Infection: a double blind, placebo controlled, factorial randomised trial to compare whether Uva Ursi or ibuprofen or a combination of both provide relief from urinary symptoms in adult women with suspected UTI

Before joining the CTU, I worked at the John Radcliffe Hospital as a research administrator for the National Institute for Health Research (NIHR) Clinical Research Network. I worked on various studies in dementias and neurodegenerative diseases - including a longitudinal study for patients with idiopathic Parkinson’s disease to better understand how Parkinson’s progresses in different ways in different people to better manage Parkinson’s in the future.

I originally trained and worked in accounting and law in the United States, but had a career change to healthcare research upon moving to the UK in 2009.